 |
|
Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions
May 30, 2006Methylphenidate (Ritalin) elevates norepinephrine levels in the brains of rats to help focus attention while suppressing nerve signal transmissions in the sensory pathways to make it easier to block out extraneous stimuli, a Philadelphia research team has found.
Their report in the Journal of Neurophysiology helps explain how a stimulant aids people with attention deficit and hyperactivity disorders to improve their focus without increasing their motor activity. Methylphenidate, prescribed under the brand name Ritalin, has been used for more than 20 years, mostly in children, to treat attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD). The drug can also help people who don't suffer either disorder to attend better to a cognitive task.
Despite its wide use, little is known about how the drug, a chemical cousin of amphetamines, produces its therapeutic effects. Researchers want to unlock the mystery of why the drug has the paradoxical effect of decreasing hyperactive behavior and increasing the ability to focus, even though it is a stimulant, said Barry Waterhouse, the study's senior author.
"We're developing a series of behavioral and electrophysiological assays for examining the actions of drugs like methylphenidate," Waterhouse said. "If we can show exactly how methylphenidate works, we may be able to produce even more effective drugs and provide a better understanding of the physiology underlying ADHD."
The study, using rats, is the first to document the increase in norepinephrine and suppression of the neuronal response in this sensory pathway of the brain. "Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats," by Philadelphia-based researchers Candice Drouin, University of Pennsylvania; Michelle Page, Thomas Jefferson University; and Barry Waterhouse, Drexel University College of Medicine appears online in the Journal of Neurophysiology, published by The American Physiological Society.
From whiskers to brain
The researchers stimulated rats' whiskers while recording the activity of the neurons in the sensory pathways that convey this sensation from the whiskers to the cerebral cortex. They compared the rat's sensory pathway response to the whisker stimulation when receiving two different doses of methylphenidate. They found that both the low and moderate doses of methylphenidate:
- Elevated norepinephrine in the area of the brain that processes information related to whisker movement. Norepinephrine helps transmit sensory information from the periphery to the brain.
- Suppressed the long latency phase of the brain's neuronal response to whisker-related sensory stimuli. Suppression of the sensory neuronal response in this way is believed to help filter extraneous stimuli, Waterhouse explained. With the extraneous stimuli out of the way, the individual is better able to attend to the important stimuli.
In addition, the researchers found that the higher dose caused the rats to increase motor activity, while the lower dose did not.
Scientists still have much to learn about methylphenidate, which has an impact on neural circuits throughout the entire brain, not just the sensory pathway studied in this paper, Waterhouse noted. The changes that occur in this sensory pathway may affect other areas of the brain and changes in other areas of the brain may affect this pathway. In addition to sensory pathways, other scientists are studying how the drug affects cognitive and emotional areas of brain.
Next steps
"This experiment adds to our knowledge of what the drug is doing at the cellular level and gives us a springboard to other studies," Waterhouse said. "One question now is, how does the individual's perception of what is an important stimulus factor into the equation?"
Researchers in this area keep in touch and share their results, Waterhouse said. One group, for example, is looking at the drug's effects on dopamine and norepinephrine in the prefrontal cortex, he noted. These results will eventually have to be combined, as changes in one area of the brain are likely to affect other areas.
"We've been thinking about this for a long time," Waterhouse said of his research. "We hope to have a good idea of the drug's action when we put it all together."
One broad question that intrigues researchers is whether ADHD traces back to the same area of the brain as attention deficit disorder, a similar condition but one in which hyperactivity isn't a symptom.
They also want to know whether Ritalin has any toxic or long-lasting effects, not only for ADHD patients, but also for individuals taking the drug who do not suffer from ADHD or ADD. Methylphenidate use is on the rise among college students who solicit prescriptions from friends or siblings diagnosed with ADHD and use the drug to postpone fatigue and stay alert and focused while studying for exams or completing projects, Waterhouse said.
American Physiological Society
"We're developing a series of behavioral and electrophysiological assays for examining the actions of drugs like methylphenidate," Waterhouse said. "If we can show exactly how methylphenidate works, we may be able to produce even more effective drugs and provide a better understanding of the physiology underlying ADHD."
The study, using rats, is the first to document the increase in norepinephrine and suppression of the neuronal response in this sensory pathway of the brain. "Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats," by Philadelphia-based researchers Candice Drouin, University of Pennsylvania; Michelle Page, Thomas Jefferson University; and Barry Waterhouse, Drexel University College of Medicine appears online in the Journal of Neurophysiology, published by The American Physiological Society.
From whiskers to brain
The researchers stimulated rats' whiskers while recording the activity of the neurons in the sensory pathways that convey this sensation from the whiskers to the cerebral cortex. They compared the rat's sensory pathway response to the whisker stimulation when receiving two different doses of methylphenidate. They found that both the low and moderate doses of methylphenidate:
- Elevated norepinephrine in the area of the brain that processes information related to whisker movement. Norepinephrine helps transmit sensory information from the periphery to the brain.
- Suppressed the long latency phase of the brain's neuronal response to whisker-related sensory stimuli. Suppression of the sensory neuronal response in this way is believed to help filter extraneous stimuli, Waterhouse explained. With the extraneous stimuli out of the way, the individual is better able to attend to the important stimuli.
In addition, the researchers found that the higher dose caused the rats to increase motor activity, while the lower dose did not.
Scientists still have much to learn about methylphenidate, which has an impact on neural circuits throughout the entire brain, not just the sensory pathway studied in this paper, Waterhouse noted. The changes that occur in this sensory pathway may affect other areas of the brain and changes in other areas of the brain may affect this pathway. In addition to sensory pathways, other scientists are studying how the drug affects cognitive and emotional areas of brain.
Next steps
"This experiment adds to our knowledge of what the drug is doing at the cellular level and gives us a springboard to other studies," Waterhouse said. "One question now is, how does the individual's perception of what is an important stimulus factor into the equation?"
Researchers in this area keep in touch and share their results, Waterhouse said. One group, for example, is looking at the drug's effects on dopamine and norepinephrine in the prefrontal cortex, he noted. These results will eventually have to be combined, as changes in one area of the brain are likely to affect other areas.
"We've been thinking about this for a long time," Waterhouse said of his research. "We hope to have a good idea of the drug's action when we put it all together."
One broad question that intrigues researchers is whether ADHD traces back to the same area of the brain as attention deficit disorder, a similar condition but one in which hyperactivity isn't a symptom.
They also want to know whether Ritalin has any toxic or long-lasting effects, not only for ADHD patients, but also for individuals taking the drug who do not suffer from ADHD or ADD. Methylphenidate use is on the rise among college students who solicit prescriptions from friends or siblings diagnosed with ADHD and use the drug to postpone fatigue and stay alert and focused while studying for exams or completing projects, Waterhouse said.
American Physiological Society
Ritalin Current Events and Ritalin News RSSHistory of hyperactivity off-base, says researcher
A Canadian researcher working in the U.K. says doctors, authors and educators are doing hyperactive children a disservice by claiming that hyperactivity as we understand it today has always existed.
ADHD medications do not cause genetic damage in children
In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University Medical Center.
A License to Drive with ADHD
If your teen can't pass a driver's test, it might not mean more time in driver's ed is needed. It might be due to ADHD.
Caffeine experts at Johns Hopkins call for warning labels for energy drinks
Johns Hopkins scientists who have spent decades researching the effects of caffeine report that a slew of caffeinated energy drinks now on the market should carry prominent labels that note caffeine doses and warn of potential health risks for consumers.
Healthy people and enhancement drugs
Healthy people are more willing to take drugs to enhance traits that are not fundamental to their identity. According to a new study in the Journal of Consumer Research, people's willingness to take a pill or drug depends on whether the trait the drug promises to enhance is one they consider fundamental.
First do no harm? UH prof taking opposite approach to treat asthma
One month of tough breathing may help asthma sufferers breathe easier in the long run, according to research from one University of Houston professor.
Mayo Clinic study indicates medication for ADHD may help student outcomes
In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD.
Pediatric Ritalin Use May Affect Developing Brain, New Study Suggests
Use of the attention deficit/hyperactivity disorder (ADHD) drug Ritalin by young children may cause long-term changes in the developing brain, suggests a new study of very young rats by a research team at Weill Cornell Medical College in New York City.
Brain-boosting pill alleviates post-chemotherapy fogginess
A drug described by some people as a "genius pill" for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as "chemo-brain," according to a University of Rochester Medical Center study.
Prenatal cocaine's lasting cellular effects
Although the "crack baby" hysteria of the 1980s was greatly exaggerated, cocaine use during pregnancy can cause subtle but disabling cognitive impairments — attention deficits, learning disabilities and emotional problems.
More Ritalin Current Events and Ritalin News Articles
 |
Ritalin Abec - 7 Gold Bearings by Ritalin This is for a set of Ritalin Abec - 7 Gold Bearings Skateboard Bearings. |
 |
The Ritalin Fact Book: What Your Doctor Won't Tell You by M.D. Peter Breggin (Author) By the author of The Antidepressant Fact Book and Talking Back to Ritalin, a straight-talking guide to the drugs used to treat ADD and ADHD. Known as the "Ralph Nader of psychiatry," Peter Breggin has been the medical expert in countless civil and criminal cases involving the use or misuse of psychoactive medications. This unusual position has given him unprecedented access to private pharmaceutical research and correspondence files, access that informs this straight-talking guide to the most-prescribed and controversial class of psychoactive medications prescribed for children. From how these drugs work in the brain to documented side and withdrawal effects, The Ritalin Fact Book is up-to-the-minute and easy-to-access. With its suggestions for non-prescriptive ways to... |
 |
Native Remedies BrightSpark, 125-Count Bottle by Native Remedies BrightSpark is a safe, non-addictive natural remedy, containing 100% homeopathic ingredients will help keep your child alert, while at the same time helping to level out moods. It will help with consistency and staying on-track with tasks and all without the risk of addiction, sedation and other side effects. BrightSpark works by assisting the body in the control of behaviors, emotions and other obstacles to effective concentration, thereby reducing distractibility and restlessness. It may be used to safely maintain health and systemic balance in the brain and nervous system, without side effects. BrightSpark is effective for children with ADD (no hyperactivity) as well as those with ADHD, and is particularly helpful for those who struggle with anger outbursts and inappropriate behavior... |
 |
Running on Ritalin: A Physician Reflects on Children, Society, and Performance in a Pill by Lawrence H. Diller (Author) In a book as provocative and newsworthy as Listening to Prozac and Driven to Distraction, a physician speaks out on America's epidemic level of diagnoses for attention deficit disorder, and on the drug that has become almost a symbol of our times: Ritalin. In 1997 alone, nearly five million people in the United States were prescribed Ritalin--most of them young children diagnosed with attention deficit disorder. Use of this drug, which is a stimulant related to amphetamine, has increased by 700 percent since 1990. And this phenomenon appears to be uniquely American: 90 percent of the world's Ritalin is used here. Is this a cause for alarm--or simply the case of an effective treatment meeting a newly discovered need? Important medical advance--or drug of abuse, as some... |
 |
Ritalin Abec - 5 Red Bearings by Ritalin This is for a set of Ritalin Abec - 5 Red Bearings Skateboard Bearings. |
 |
BrightSpark for ADD and ADHD, Natural, Children, Teens, Help your child focus by Native Remedies Too often, doctors and psychiatrists quickly prescribe powerful psychiatric drugs such as Ritalin, Concerta and Adderall to treat the symptoms of ADD and ADHD, subjecting sufferers to unnecessary risk and possibly devastating side effects. BrightSpark for ADD and ADHD is a 100% safe, non-addictive alternative treatment for ADD and ADHD, without the risks and side effects of prescription psychiatric drugs. BrightSpark is a proven, complex homeopathic remedy, specially formulated by a practicing Clinical Psychologist to safely and effectively treat the symptoms of ADD and ADHD. In combination with a healthy lifestyle and diet which excludes excess sugar, stimulants, artificial preservatives and colorants, BrightSpark acts as a calmative remedy which can focus the mind and improve... |
 |
101 Reasons to Avoid Ritalin Like the Plague by Howard Glasser (Author) This book captures the bigger picture of all that is sacrificed with the pivotal decision to put a child on Ritalin or medications. There are so many physical and psychological side-effects that never get mentioned to the parent who is seeking help or being pressured by the school to do something about their child's behavior or poor performance at school. This book fights for the parent to have full disclosure of the truth. Parents are never told: "Oh by the way, once in a while a child dies simply by taking their prescribed medication, or by the way, children on stimulant medications have twice the future rate of drug abuse, or by the way, 1/3 of all children on these medications develope symptoms of obsessive compulsive behavior within the first year. Most doctors don't tell parents... |
 |
Ritalin Nation: Rapid-Fire Culture and the Transformation of Human Consciousness by Richard J. Degrandpre (Author) By the year 2000, the USDA predicts that 15 percent--8 million--of our children will be on their way to using Ritalin. In this illuminating investigation of the epidemic of attention deficit disorder (ADD) and its most widely prescribed treatment, the powerful psychostimulant Ritalin, psychologist Richard DeGrandpre sounds a warning: we may well be failing our children by treating symptoms and not causes with a quick-fix and ultimately unsatisfactory solution. Drawing on the latest findings from developmental, psychobiological, and social scientific research, DeGrandpre "criticizes America's obsession with performance and quick satisfaction and the country's reliance on Ritalin [as] a performance-enhancing drug" (Natural Health). He cautions that our society-wide rush to more, and faster,... |
 |
Ritalin Abec - 5 Chrome Bearings by Ritalin This is for a set of Ritalin Abec - 5 Chrome Bearings Skateboard Bearings. |
 |
Investigative Reports: Generation Rx - Reading, Writing, and Ritalin Starring: Bill Kurtis A look at how America's love affair with prescription drugs has moved into the playpen.Today, 4 million children begin their school day by taking a small yellow pill, Ritalin, to control their hyperactivity. Since 1990, there has been a 700% increase in the use of the stimulant. And more than 2.5 million prescriptions for anti-depressants were written for pre-schoolers and adolescents. We look at all sides of the issue and talk to pediatricians, psychiatrists, teachers, parents, and children. |
| © 2009 BrightSurf.com |